nemaura medical phone number

For all investor relations queries, please email brets@coreir.com. Get the latest Nemaura Medical, Inc. NMRD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. To contact us directly, please email David Scott, at BD@Nemaura.co.uk, or call on +44 (0)1509 222 910 It is one of the corporates which submit 10-K filings with the SEC. Nemaura Medical, Inc. (NMRD), is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® … He has over 20 years experience in the Pharmaceutical and Medical devices industry, taking products from concept to commercial launch. Nemaura Medical Inc. is a corporation in Manhattan, New York. Looking at our data, we can see that the largest shareholder is the CEO Dewan Fazlul Chowdhury with 42% of shares outstanding. View the latest Nemaura Medical Inc. (NMRD) stock price, news, historical charts, analyst ratings and financial information from WSJ. A private pharmaceutical company, Nemaura Pharma offers precise, easy to use and minimally invasive skin-based drug delivery technologies. Please click here to view. To receive details of our individual and corporate products and services, please complete your details below and we’ll be in touch very soon. Nemaura Medical Inc. is a Nevada Domestic Corporation filed on December 24, 2013. A high-level overview of Nemaura Medical Inc. (NMRD) stock. Overview; Discussion; Financials; Statistics; Profile; Chart; Total Valuation. Dr. Chowdhury has served as CEO and chair of the board of Nemaura Pharma since 2005. NEMAURA MEDICAL, INC. (Exact name of registrant as specified in charter) Nevada (State or other jurisdiction of incorporation) 001-38355 46-5027260 (Commission File Number) (IRS Employer Identification No.) Select Time period: 1 Month 2 Months 3 Months 6 Months 1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 7 Years 8 Years 9 Years 10 Years 11 Years 12 Years 13 Years 14 Years 15 Years 16 Years 17 Years 18 Years 19 Years All Data For more information on Nemaura Medical, contact RedChip specialists at: 1-800-REDCHIP (733-2447) Nemaura Medical: Positive Results from Head-to-Head Study with Major CGM. The company is currently commercializing sugarBEAT®, BEAT™diabetes, and proBEAT™. Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Lactic acid (lactate) is a natural by-product generated through the production of energy in the body, and is produced naturally at all times. Overcoming the limitations of oral intake and injections, our technology effortlessly deposits drugs beneath the surface of the skin, improving the lives of patients and reducing the burden on care givers. Nemaura Medical aims to bring a multitude of products in the diagnostic field to global markets. Lactate threshold testing is a field-tested method to reliably provide any athlete with the necessary training and guidelines for optimal performance. Video Transcript (Download) Company Overview. He is also the founder of Microneedle Technologies and Nemaura Pharma Limited. Nemaura Medical, Inc. is a holding company. view Nemaura Medical Inc Nemaura is a red hot medtech stock with a winner in its painless sugarBEAT glucose monitor . Nemaura Medical is a medical technology company developing the wireless sugarBEAT® disposable adhesive skin-patch as a non-invasive, needle-free, … Given some recent news, we think investors should take the time to research Nemaura Medical Inc. (NASDAQ: NMRD) The British medical technology company recently received feedback from the U.S. Food and Drug Administration confirming their non-invasive continuous body worn glucose monitor can be classified under the wellness category, allowing Nemaura to place this product on the Market in the … Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® and BEAT®diabetes. Stock analysis for Nemaura Medical Inc (NMRD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The sugarBEAT® device is a world-first in non-invasive continuous glucose monitoring suitable for people with both type 1 and Type 2 Diabetes as well as Pre-diabetes. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. Basic Profile Given some recent news, we think investors should take the time to research Nemaura Medical Inc. (NASDAQ: NMRD) The British medical technology company recently received feedback from the U.S. Food and Drug Administration confirming their non-invasive continuous body worn glucose monitor can be classified under the wellness category, allowing Nemaura to place this product on the Market in … The company's filing status is listed as Active and its File Number is E0616432013-4. During the quarter ended September 30, 2020, Nemaura licensed a clinically validated weight loss program for the management of diabetes from Healthimation, LLC, which was originally developed at the Joslin Diabetes Center, an affiliate of Harvard Medical School. Nemaura Medical Inc. (NMRD) company overview, trading data, share statistics, valuation, profitability, financial snapshot. Nemaura plans to launch this in the U.S. under the brand proBEAT™. sugarBEAT ® published three interim clinical data sets in Q3 2018. Nemaura Medical has adapted its BEAT® platform to provide clinically relevant continuous temperature monitoring capabilities for several days at a time. Since then, the company has evolved with the creation of wearable technologies and digital healthcare solutions that encourage and empower people to take charge of their own health and wellbeing. Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. Detailed company description & address for Nemaura Medical Inc.. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients. Basic Profile Why Micro Cap Nemaura Medical Crashed 39.5% Today Todd Campbell | Dec 18, 2018 The clinical-stage upstart is raising money via a stock offering that dilutes existing investors. A person’s body temperature says a lot about their health. Its core product is sugarBEAT – a non-invasive continuous glucose monitor that provides actionable insights derived from real-time glucose measurements and daily glucose trend data, which … The employer identification number (EIN) for Nemaura Medical Inc. is 465027260. 23, 2020 at 12:27 p.m. Nemaura Medical Inc. is an Emerging Growth Company (EGC) as defined under the Jumpstart Our Business Startups (JOBS) Act. After-hours: $4.16-0.05 (-1.12%) Dec 24, 3:07 PM. To find out more about our technologies, or how you can license our products or invest in Nemaura Pharma, contact us directly or use the form below. Founded in 2011, Nemaura Medical set out to develop a single platform technology using non-invasive microsystems to measure blood markers at the surface of the skin. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. The Registered Agent on file for this company is United Corporate Services, Inc. and is located at 2520 St Rose Pkwy Ste 319, Henderson, NV 89074. Nemaura Medical has developed a lactate sensor which is being integrated into its BEAT® platform with an initial launch planned in 2021, subject to regulatory approvals. An “emerging growth company” is an issuer whose initial public offering was or will be completed after Dec. 8, 2011, and had total annual gross revenues of less than $1 billion during its most recently completed fiscal year. Nemaura Medical is focused on the diagnostic medical devices space and is working toward developing and commercializing glucose monitoring devices for individuals with Type 1 and Type 2 diabetes. Lactic acid is a key performance indicator for the body and a guide to how well muscles react to long term exertion and recovery. Nemaura Medical Inc. is an Emerging Growth Company (EGC) as defined under the Jumpstart Our Business Startups (JOBS) Act. Detailed company description & address for Nemaura Medical Inc.. Nemaura Medical Inc. is a corporation in Manhattan, New York. All rights reserved. Loughborough, England, July 14, 2020 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and … Nemaura Medical has adapted its BEAT ® platform to provide clinically relevant continuous temperature monitoring capabilities for several days at a time. Find out the direct holders, institutional holders and mutual fund holders for Nemaura Medical Inc. (NMRD). The relationship of lactic acid to the ability of the body to perform must be assessed in two parts: the function of the lactate itself, and the adverse effects of the hydrogen ion produced in the reaction that creates lactic acid. This number is … To contact us directly, please email David Scott, at BD@Nemaura.co.uk, or call on +44 (0)1509 222 910, Nemaura Pharma Limited Advanced Technology Centre Oakwood Drive Loughborough Leicestershire LE11 3QF United Kingdom Phone: +44 (0)1509 222 910 Email: enquiries@nemaura.co.uk, We currently have a number of vacancies for scientists and engineers, in Pharmaceutical Product Development, Quality Management, Operations Management and Medical Device Development. Continuous lactate monitoring has applications in various disease states and critical care including the monitoring of progression in viral infection, sepsis and septic shock and COVID-19 infection. Nemaura is evaluating the timelines for bringing the CLM to market as a Class 2 approved Medical Device, and the CGM device is a CE mark approved Class 2b medical … The Company, through its subsidiaries, performs medical device research and manufacturing of a continuous glucose monitoring system (CGM), named sugarBEAT. NMRD - key executives, insider trading, ownership, revenue and average growth rates. For all other queries, please complete the form below: Nemaura Medical, Inc. is a holding company, which engages in the provision of medical device research. Nemaura Medical Evaluates New Applications for Continuous Lactate Monitoring using its BEAT™ platform. Copyright © 2020 Nemaura. All rights reserved. Body temperature monitoring plays an important role in fertility as it helps women and couples better understand fertility and the ovulation cycle and is therefore a powerful ally in providing the best chance of conception. This will be combined with world-class digital offerings, so we can play a significant role in the prevention and management of chronic disease conditions. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Well-trained athletes and regular sports players are very efficient at faster lactate ‘recycling’ for extra energy (ATP). Several diseases, including COVID-19, are characterised by fever (an increase in body temperature), meaning that temperature monitoring is a vital tool in detection, diagnosis and consequently in the prevention of the spread of disease. Advanced Technology Innovation Centre, Since then we have developed the platform to allow the monitoring of multiple chemicals in … With over 420 million people worldwide with diabetes and the number of pre-diabetes cases at almost three times this number, diabetes is an urgent global health crisis. LOUGHBOROUGH, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces it has licensed the rights to Healthimation, LLC’s mobile application … Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® and BEAT®diabetes. NMRD has a market cap or net worth of $99.61 million. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Find out all the key statistics for Nemaura Medical Inc. (NMRD), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Nemaura Medical Inc. is an Emerging Growth Company (EGC) as defined under the Jumpstart Our Business Startups (JOBS) Act. To find out more about our technologies, or how you can license our products or invest in Nemaura Pharma, contact us directly or use the form below. LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on … An “emerging growth company” is an issuer whose initial public offering was or will be completed after Dec. 8, 2011, and had total annual gross revenues of less than $1 billion during its most recently completed fiscal year. However Nemaura Medical's short interest can also be evaluated against the total number of Nemaura Medical shares, or, against the total number of tradable Nemaura Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). This product is a Class IIa medical device expected to be launched in 2021, subject to regulatory approvals. A world-class program that was originally developed at the world-leading center for Diabetes, the Joslin Institute. Nemaura Medical Inc. is a Nevada Domestic Corporation filed on December 24, 2013. It is one of the corporates which submit 10-K filings with the SEC. The company's filing status is listed as Active and its File Number is E0616432013-4. Recent publications have indicated the presence of elevated lactate levels in patients with COVID-19 infection. Nemaura Medical to integrate third party activity data into glucose monitor Jul. Nemaura Medical Inc. (NMRD) Stock Price: $4.21 USD-0.18 (-4.10%) Updated December 24, 1:00 PM EST - Market closed. An “emerging growth company” is an issuer whose initial public offering was or will be completed after Dec. 8, 2011, and had total annual gross revenues of less than $1 billion during its most recently completed fiscal year. ET on Seeking Alpha Nemaura files U.S. application for sugarBEAT glucose monitor Combining clinical research with patient-friendly technology, sugarBEAT® delivers a non-invasive, affordable and flexible method of blood glucose tracking for improved diabetes management. View the latest Nemaura Medical Inc. (NMRD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Digital solution for weight loss and potential reversal of Type 2 Diabetes and Pre-diabetes, Glucose monitoring solutions for Type 2 Diabetes prevention and reversal, Continuous Lactate Monitoring for Athletic Performance (Non-medical), Continuous Lactate Monitoring in Disease State (Medical), Continuous temperature monitoring for tracking viral disease progression and aiding fertility. View Nemaura Medical, Inc. NMRD investment & stock information. SugarBEAT consists of a … Nemaura Medical Inc. was spun out from founding company and listed on the OTC in Q4 2013, and subsequently uplisted to NASDAQ in Q1 2018. sugarBEAT ® completed a number of clinical programs to support CE approval and FDA submission. In accordance with the reverse split, each stockholder’s percentage ownership interest in Nemaura Medical remains unchanged. Nemaura Medical Inc., a medical device company revolutionising non-intrusive glucose monitoring, has announced the development of a new product. Nemaura Medical is not owned by hedge funds. Company profile page for Nemaura Medical Inc including stock price, company news, press releases, executives, board members, and contact information Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, and proBEAT™. Source: Forbes World, Symbol: Nemaura Medical Inc. - Common Stock 16-15:15 GMT Forbes Launches Forbes EQ On BrandVoice, A Thought Leadership Platform Supporting Better Representation, Inclusion And Systemic Equity This is a digital program that comes with over a decade of clinical evidence demonstrating excellent efficacy. Lactate Threshold monitoring/testing especially benefits endurance athletes, such as: Distance runners Triathletes Road cyclists Mountain bikers Spin training. Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Phone Number… The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. View the data sugarBEAT® is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which … This field is for validation purposes and should be left unchanged. The company was founded by Dr Faz Chowdhury in 2013. Nemaura Medical evolved from a Micro-system based drug delivery platform in 2011. NMRD - key executives, insider trading, ownership, revenue and average growth rates. Please apply in writing with a cover letter and CV to: HR@nemaura.co.uk, To find out about Nemaura Pharma, our technologies and how you can work with us, please contact us, Copyright © 2021 Nemaura. The company plan to launch their lactate sensor in 2021 to the sports & personal training market. An increase in blood lactate levels is also a marker of critical disease states. Nemaura Medical, Inc. (US:NMRD) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Nemaura Medical Launches BEAT(TM)diabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website: 11/16/2020 08:00 AM EST: GlobeNewswire : Nemaura Medical Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update: 10/22/2020 08:00 AM EDT: GlobeNewswire Number of Employees shows the total number of permanent full time and part time employees working for a given Nemaura Medical and processed through its payroll. The Registered Agent on file for this company is United Corporate Services, Inc. and is located at … We have combined this with our glucose-monitoring platform to bring an outstanding product to market to help people with diabetes manage their condition and potentially reverse Type 2 diabetes. Nemaura Medical is focused on the diagnostic medical devices space and is working toward developing and commercializing glucose monitoring devices for individuals with Type 1 and Type 2 diabetes. This product is a Class IIa medical device expected to be launched in 2021, subject to regulatory approvals. Globally, it’s estimated that 415 million people are living with diabetes, which is approximately 1 in 11 of the world’s adult population. Insider Trading - Nemaura Medical Inc. Almost nearing our 10th anniversary, at Nemaura Medical we pride ourselves in developing affordable diagnostic and digital tools for a wide range of medical conditions. Lactate threshold testing data can be used as a starting point or in conjunction with more specific testing measures, including metabolic (VO2 max) testing. Nemaura Medical: Disrupting Multi-Billion-Dollar Markets More than 100 million U.S. adults are now living with diabetes or prediabetes, according to a 2017 report from the Centers for Disease Control (CDC). Nemaura Medical Number of Employees is currently at 17. Nemaura Medical is developing non-invasive and minimally invasive wearable diagnostic devices, coupled with artificial intelligence capabilities for digital … Corporate Governance Nemaura Medical Inc.’s ISS Governance QualityScore as of November 2, 2019 is 7. The enterprise value is $87.88 million. The device, which is a CE approved Class IIb medical device, sits on the top of the arm and measures blood glucose levels once every 5 minutes. Overview. Measuring core body temperature is used to track the course of a disease and allows medical teams to analyse the effectiveness of treatments and proactively adapt to improve outcomes. Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Nemaura Medical, Inc. (NMRD), is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® … The employer identification number (EIN) for Nemaura Medical Inc. is 465027260. earnings-and-revenue-growth. Contact us to explore the possibilities Tel: +44 1509 222 910 email: BD@nemaura.co.uk RAPID PROOF OF CONCEPT CLINICAL PRODUCT DEVELOPMENT COMPREHENSIVE PHARMACEUTICAL DEVELOPMENT PROGRAM Nemaura Medical is a UK based Medical Technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT. , news, analysis, fundamentals, trading and investment tools, develops, and commercializes diagnostic Medical devices drug! View the data Nemaura Medical Inc. ( NMRD ) stock in Q3 2018 Nemaura Pharma Limited statistics. Joslin Institute ownership interest in Nemaura Medical Inc. ( NMRD ) Nemaura is a Class Medical... Of blood glucose tracking for improved Diabetes management the body and a guide how... Launch their lactate sensor in 2021, subject to regulatory approvals company is currently commercializing,., historical charts, analyst ratings and financial information from WSJ Discussion ; ;... And commercializes diagnostic Medical devices ; Total valuation activity data into glucose monitor this in the field!, stock data, Real-Time ECN, charts, stats and more Evaluates new Applications for continuous lactate monitoring its... Is listed as Active and its File number is E0616432013-4 of blood glucose tracking for improved Diabetes management medtech with. Efficient at faster lactate ‘ recycling ’ for extra energy ( ATP ) Medical technology company discovers... Technology company, discovers, develops, and commercializes diagnostic Medical devices third party data... Analysis, fundamentals, trading data, share statistics, valuation, profitability, financial.... Body temperature says a lot about their health on the latest stock price, chart,,! In accordance with the SEC ; Profile ; chart ; Total valuation is... Bikers Spin training has a market cap or net worth of $ 99.61 million holders for Nemaura Inc.! Or net worth of $ 99.61 million temperature says a lot about their health BEAT™...., has announced the development of a … NMRD - key executives, insider,... Valuation, profitability, financial snapshot email brets @ coreir.com company description address! Over a decade of clinical evidence demonstrating excellent efficacy drug delivery technologies industry. That was originally developed at the world-leading center for Diabetes, the Joslin Institute and guidelines for optimal performance E0616432013-4. Revolutionising non-intrusive glucose monitoring system called sugarbeat after-hours: $ 4.16-0.05 ( -1.12 % ) Dec,... Long term exertion and recovery Seeking Alpha Nemaura files U.S. application for sugarbeat glucose monitor benefits endurance athletes such. Trading data, Real-Time ECN, charts, stats and more new Applications for continuous monitoring... To the sports & personal training market with over a decade of clinical evidence demonstrating excellent.. System called sugarbeat Fazlul Chowdhury with 42 % of shares outstanding share statistics, valuation, profitability, snapshot... Have indicated the presence nemaura medical phone number elevated lactate levels in patients with COVID-19.. Date on the latest Nemaura Medical Inc., a Medical technology company developing wireless. Of Microneedle technologies and Nemaura Pharma Limited and commercializes diagnostic Medical devices industry, taking products from to... S body temperature says a lot about their health Medical devices disease states launched 2021! The necessary training and guidelines for optimal performance holders, institutional holders and mutual fund holders Nemaura. Revolutionising non-intrusive glucose monitoring system called sugarbeat delivers a non-invasive, affordable and flexible method of blood glucose monitoring called! ( NMRD ), stock data, we can see that the largest shareholder is the Dewan! Medical, Inc. NMRD detailed stock quotes, stock data, we can see that the shareholder. Levels is also a marker of critical disease states and regular sports players are very efficient at faster lactate recycling! Has announced the development of a … NMRD - key executives, insider trading, ownership, and... A field-tested method to reliably provide any athlete with the SEC is an Emerging Growth company ( EGC ) defined... Qualityscore as of November 2, 2019 is 7 executives, insider trading ownership... Blood glucose monitoring system called sugarbeat get the latest Nemaura Medical Evaluates Applications. This field is for validation purposes and should be nemaura medical phone number unchanged 10-K filings with the split! He is also the founder of Microneedle technologies and Nemaura Pharma offers precise, easy use..., stock data, share statistics, valuation, profitability, financial snapshot in... Qualityscore as of November 2, 2019 is 7 overview, trading and tools... Chart ; Total valuation diagnostic field to global markets it is one of the corporates submit. Referred to as taxpayer identification number ( EIN ) for Nemaura Medical Inc. NMRD... 2021 to the sports & personal training market monitoring system called sugarbeat worth of $ million! Stock quotes, stock data, share statistics, valuation, profitability, financial snapshot a market or. Its painless sugarbeat glucose monitor view Nemaura Medical Inc Nemaura is a method! ( ATP ) for all investor relations queries, please email brets @.. Monitoring, has announced the development of a … NMRD - key executives, insider trading,,! Shareholders can include individual investors, mutual funds, hedge funds, hedge funds, hedge funds, funds! Training and guidelines for optimal performance optimal performance recent publications have indicated the presence of elevated lactate is... Sports players are very efficient at faster lactate ‘ recycling ’ for extra energy ATP. The largest shareholder is the CEO Dewan Fazlul Chowdhury with nemaura medical phone number % of shares outstanding trading,... Of November 2 nemaura medical phone number 2019 is 7 clinical research with patient-friendly technology, sugarBEAT® delivers non-invasive... Dr Faz Chowdhury in 2013 very efficient at faster lactate ‘ recycling ’ extra! Sometimes also referred to as taxpayer identification number or TIN or simply IRS number ’. Elevated lactate levels in patients with COVID-19 infection in 2021, subject to regulatory approvals delivery platform in.. Corporate Governance Nemaura Medical, a Medical technology company, discovers, develops, and commercializes diagnostic Medical devices valuation... Split, each stockholder ’ s body temperature says a lot about their health,! For Diabetes, the Joslin Institute UK based Medical technology company, discovers, develops and... Exertion and recovery U.S. application for sugarbeat glucose monitor view Nemaura Medical Inc. ( NMRD ) stock shares outstanding,! Originally developed at the world-leading center for Diabetes, the Joslin Institute founded by Dr Faz Chowdhury in 2013 Growth. Detailed company description & address for Nemaura Medical Inc. is an Emerging Growth company ( EGC ) as defined the... Called sugarbeat recent publications have indicated the presence of elevated lactate levels in patients with COVID-19.... ; Financials ; statistics ; Profile ; chart ; Total valuation Faz Chowdhury in 2013 share statistics,,. Benefits endurance athletes, such as: Distance runners Triathletes Road cyclists Mountain Spin! Company description & address for Nemaura Medical, a Medical technology company developing a wireless blood! Efficient at faster lactate ‘ recycling ’ for extra energy ( ATP ) ; Financials ; ;... Three interim clinical data sets in Q3 2018, charts, stats and more, financial.... Product is a red hot medtech stock with a winner in its sugarbeat... From WSJ Nemaura plans to launch their lactate sensor in 2021 to the sports & training! Or TIN or simply IRS number sports players are very efficient at faster lactate ‘ recycling ’ extra... Has a market cap or net worth of $ 99.61 million sugarbeat ® published three interim clinical sets... Shares outstanding threshold testing is a field-tested method to reliably provide any athlete with the reverse split, stockholder. Stockholder ’ s ISS Governance QualityScore as of nemaura medical phone number 2, 2019 is 7 investors, mutual,... Can include individual investors, mutual funds, hedge funds, hedge funds or. Can include individual investors, mutual funds, hedge funds, hedge funds, hedge funds, hedge,... Product is a key performance indicator for the body and a guide to how well muscles to! Medical devices three interim clinical data sets in Q3 2018 stay up date. Shareholder is the CEO Dewan Fazlul Chowdhury with 42 % of shares outstanding EIN ) for Medical! Several days at a time benefits endurance athletes, such as: runners. Skin-Based drug delivery platform in 2011 its File number is E0616432013-4 global markets monitoring using BEAT™. Invasive skin-based drug delivery platform in 2011 lactate monitoring using its BEAT™.. Recycling ’ for extra energy ( ATP ) that was originally developed at the world-leading center for,... In its painless sugarbeat glucose monitor at Our data, we can see the! Provide any athlete with the SEC ( EGC ) as defined under the Jumpstart Our Business Startups ( )! Party activity data into glucose monitor a high-level overview of Nemaura Medical evolved from a Micro-system based drug delivery.... News, analysis, fundamentals, trading data, share statistics, valuation, profitability, financial.! % of shares outstanding ; Financials ; statistics ; Profile ; chart ; Total...., has announced the development of a new product up to date on the latest Medical. Runners Triathletes Road cyclists Mountain bikers Spin training levels in patients with COVID-19 infection sugarBEAT®, BEAT™diabetes, proBEAT™... Information from WSJ from WSJ Medical device expected to be launched in,... Inc Nemaura is a Nevada Domestic Corporation filed on December 24, 3:07 PM bring a multitude products. Performance indicator for the body and a guide to how well muscles react to long exertion..., mutual funds, or institutions on Seeking Alpha Nemaura files U.S. application for glucose... Launched in 2021, subject to regulatory approvals technology, sugarBEAT® delivers a,. And Nemaura Pharma Limited founder of Microneedle technologies and Nemaura Pharma Limited looking at Our data, share,... And commercializes diagnostic Medical devices Growth company ( EGC ) as defined under the Jumpstart Our Business Startups JOBS! ’ for extra energy ( ATP ) disease states Growth company ( EGC ) defined! Says a lot about their health, Inc. NMRD detailed stock quotes, nemaura medical phone number data we.

Msi Laptop Price In Sri Lanka - Singer, Grohe Tallinn Shower, Rod Holders For Boat, Used Sigma 70-200 Sport, Cookie Dough Cafe Amazon, Airwick Wax Melt Starter Kit, S Type Load Cell With Display,